NovaBay Pharmaceuticals, Inc. Non-current Revenue (Deferred)

Non-current Revenue (Deferred) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-current Revenue (Deferred) growth rates and interactive chart.


Highlights and Quick Summary

  • Non-current Revenue (Deferred) for the quarter ending December 31, 2018 was $184 Thousand (a -13.62% decrease compared to previous quarter)
  • Year-over-year quarterly Non-current Revenue (Deferred) decreased by -29.5%
  • Annual Non-current Revenue (Deferred) for 2018 was $184 Thousand (a -77.56% decrease from previous year)
  • Annual Non-current Revenue (Deferred) for 2017 was $820 Thousand (a -64.55% decrease from previous year)
  • Annual Non-current Revenue (Deferred) for 2016 was $2.31 Million (a -5.09% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-current Revenue (Deferred) of NovaBay Pharmaceuticals, Inc.

Most recent Non-current Revenue (Deferred)of NBY including historical data for past 10 years.

Interactive Chart of Non-current Revenue (Deferred) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Non-current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2018 $0.18 $0.21 $0.24 $0.26 $0.18
2017 $0.82 $1.86 $2.3 $2.12 $0.82
2016 $2.31 $2.16 $2.32 $3.3 $2.31
2015 $2.44 $2.21 $2.37 $2.17 $2.44
2014 $2.17 $2.38 $1.76 $1.75 $2.17
2013 $1.67 $1.2 $1.13 $0.8 $1.67
2012 $0.73 $0.28 $0.59 $0.98 $0.73
2011 $1.06 $1.37 $1.06

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology